At 11:32 am today ctic released the result of phase 2 of pacritinib. According to the report, the result goes along pretty well, no serious side effect reported. I thought investors should have positive reaction to this result but they sell off any way.
Big Wall Street bad guys such as GS try to scare investors to invest in reits so they can buy their cheap shares. In contrary, in 2008 GS coaxed investors to buy derivatives and GS short them at the same time. I'm sure after they buy enough reits shares or no one is willing to sell any more then their analysts will issue upgrade for reits with the reason reits provides solid dividend instead of saying the increase of interest would hurt reits like they said now.
Exactly. GS is the biggest #$%$ of all Wall Street #$%$s. They downgrade NLY but they may buy NLY right now. They did the same thing when they recommended others to buy derivatives and they shorted them at the same time in 2008.
Every body knows Chinese controls rare earth on the world. Of course they don't want any one interferes their monopoly and they have plenty of money. Sooner or later they will buy MCP because MCP is a very good target. for them to enter US market, the same way they bought Smithfield Co.
CTIC has market cap 194 mil and receives upfront 60 mil and 40 mil next year up to 112 mil from Baxter for develop and commercialize pacritimib worldwide. This positive news will last for years to come.
Remember the market cap of CTIC is only 194 mil. This is a huge run up for CTIC.
FDA said SRPT filing is prematured is not a sky-collapse for SRPT. They still do more tests and apply later. This is investor overreacting plus short selling. Wait a couple of days, SRPT WILL recover substantially. This is really buy opportunity.